TPH2 — MultiTargetDB

Summary

KEGG Pathways (4)

Associated Diseases (2)

Top Co-occurrence Targets

InChIKey	pChEMBL	Type	Targets	Clinical
`ZNSPHKJFQDEABI`	8.2	IC50	2	—
`PNOPLSUWJWBDPM`	8.0	IC50	2	—
`DKITUBGXJSKLQY`	7.8	IC50	2	—
`DXPLGNDECHMRIY`	7.8	IC50	2	—
`SKSXYOVDFRKNIW`	7.8	IC50	2	—
`HWQDMPMSOWDUDB`	7.8	IC50	2	—
`BKWIQGROOGVOLF`	7.8	IC50	2	—
`FAJFZWRIIDOQRK`	7.8	IC50	2	—
`FJDRFUYWOVFIPP`	7.8	IC50	2	—
`CTEOQFKRPWTAIL`	7.8	IC50	2	—
`JKWJZVDIZBVTCO`	7.8	IC50	2	—
`PWAILKFEUQGCNZ`	7.8	IC50	2	—
`UWFUUDKUXRSKEG`	7.8	IC50	2	—
`AQAIBLKSANVCAM`	7.8	IC50	2	—
`MFIZHXNLSAXVHZ`	7.8	IC50	2	—
`RMUJKYXKGUURTR`	7.8	IC50	2	—
`CRJSCQHFVZPKAE`	7.7	IC50	2	—
`FTJJBFCHNOJGSV`	7.7	IC50	2	—
`GVYDINLTFQEVNV`	7.7	IC50	2	—
`KRRLVHYAVVYHJV`	7.7	IC50	2	—
`LBRZMJWEEGYHOQ`	7.7	IC50	2	—
`YITCJRJDTZUJTI`	7.7	IC50	2	—
`RLVQMIFZROVBAO`	7.7	IC50	2	—
`VOGFVOSMULGXOF`	7.7	IC50	2	—
`NKIVCYDZYCBMLF`	7.6	IC50	2	—
`VAZSMDMETIFIBH`	7.6	IC50	2	—
`FAMXOEFEIFTUNL`	7.6	IC50	2	—
`JPPYMGGKCZLRLD`	7.6	IC50	2	—
`VHQNCXRAUFMYLH`	7.6	IC50	2	—
`CHNXRVLXFOXYEC`	7.6	IC50	2	—
`WLKDJNMHCQGERZ`	7.6	IC50	2	—
`JPVHOGWXZNTUSP`	7.6	IC50	2	—
`ZLJGIHROKVFFHD`	7.6	IC50	2	—
`QMMNAVKAIUPSEK`	7.5	IC50	2	—
`CYHSUTOUGLUUPG`	7.5	IC50	2	—
`NXXFUMVQYJTVBE`	7.5	IC50	2	—
`OGPHSLXZCKRAAL`	7.5	IC50	2	—
`IRNPAJSSYMZGCT`	7.5	IC50	2	—
`RDEPTIRSFNDUOK`	7.5	IC50	2	—
`JWRCWVHWZMJADV`	7.5	IC50	2	—
`XTQKTGYWGJOGNR`	7.5	IC50	2	—
`BOONQMFXDYTUQF`	7.5	IC50	2	—
`CGLOGXGDGPMEGS`	7.4	IC50	2	—
`DYETZZRDJHRRPW`	7.4	IC50	2	—
`NWAZKHUQSQHSTL`	7.4	IC50	2	—
`UMMSVJPWXXQOHK`	7.4	IC50	2	—
`VBYFKIYMVQBKPN`	7.4	IC50	2	—
`ADTIQGKCZQHSQW`	7.4	IC50	2	—
`SMDQFUGCZCQACS`	7.4	IC50	2	—
`CPISMKNBAXDQEB`	7.4	IC50	2	—